Single cell multiomic analysis of T cell exhaustion in vitro.
T-cell exhaustion
molecular cytometry
multiomics
single-cell analysis
Journal
Cytometry. Part A : the journal of the International Society for Analytical Cytology
ISSN: 1552-4930
Titre abrégé: Cytometry A
Pays: United States
ID NLM: 101235694
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
27
07
2021
received:
29
10
2020
accepted:
27
07
2021
pubmed:
15
8
2021
medline:
2
2
2022
entrez:
14
8
2021
Statut:
ppublish
Résumé
T-cell activation is a key step in the amplification of an immune response. Over the course of an immune response, cells may be chronically stimulated, with some proportion becoming exhausted; an enormous number of molecules are involved in this process. There remain a number of questions about the process, namely: (1) what degree of heterogeneity and plasticity do T-cells exhibit during stimulation? (2) how many unique cell states define chronic stimulation? and (3) what markers discriminate activated from exhausted cells? We addressed these questions by performing single-cell multiomic analysis to simultaneously measure expression of 38 proteins and 399 genes in human T cells expanded in vitro. This approach allowed us to study -with unprecedented depth-how T cells change over the course of chronic stimulation. Comprehensive immunophenotypic and transcriptomic analysis at day 0 enabled a refined characterization of T-cell maturational states and the identification of a donor-specific subset of terminally differentiated T-cells that would have been otherwise overlooked using canonical cell classification schema. As expected, activation downregulated naïve-cell markers and upregulated effector molecules, proliferation regulators, co-inhibitory and co-stimulatory receptors. Our deep kinetic analysis further revealed clusters of proteins and genes identifying unique states of activation, defined by markers temporarily expressed upon 3 days of stimulation (PD-1, CD69, LTA), markers constitutively expressed throughout chronic activation (CD25, GITR, LGALS1), and markers uniquely up-regulated upon 14 days of stimulation (CD39, ENTPD1, TNFDF10); expression of these markers could be associated with the emergence of short-lived cell types. Notably, different ratios of cells expressing activation or exhaustion markers were measured at each time point. These data reveal the high heterogeneity and plasticity of chronically stimulated T cells. Our study demonstrates the power of a single-cell multiomic approach to comprehensively characterize T-cells and to precisely monitor changes in differentiation, activation, and exhaustion signatures during cell stimulation.
Identifiants
pubmed: 34390166
doi: 10.1002/cyto.a.24496
pmc: PMC9293072
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-44Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 BD Biosciences. Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.
Références
Scand J Clin Lab Invest. 2008;68(3):233-41
pubmed: 17917998
Annu Rev Med. 2018 Jan 29;69:301-318
pubmed: 29414259
Nat Biotechnol. 2017 Oct;35(10):936-939
pubmed: 28854175
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
RNA. 2016 Jun;22(6):839-51
pubmed: 27022035
Cytometry A. 2010 Jul;77(7):614-22
pubmed: 20583275
Trends Mol Med. 2016 Dec;22(12):1000-1011
pubmed: 27825667
Science. 2011 Apr 22;332(6028):472-4
pubmed: 21415320
Science. 2011 May 6;332(6030):687-96
pubmed: 21551058
Am Soc Clin Oncol Educ Book. 2016;35:e493-503
pubmed: 27249758
Eur J Immunol. 2019 Oct;49(10):1457-1973
pubmed: 31633216
Nat Rev Immunol. 2019 Nov;19(11):665-674
pubmed: 31570879
PLoS Biol. 2006 Oct;4(10):e309
pubmed: 17048983
Cell Syst. 2018 May 23;6(5):612-620.e5
pubmed: 29605184
Curr Opin Immunol. 2013 Apr;25(2):214-21
pubmed: 23298609
Science. 2015 Feb 6;347(6222):1258367
pubmed: 25657253
J Virol. 2004 Jun;78(11):5535-45
pubmed: 15140950
Immunity. 2007 Sep;27(3):393-405
pubmed: 17892848
Cytometry A. 2022 Jan;101(1):27-44
pubmed: 34390166
Cell. 2019 Feb 7;176(4):775-789.e18
pubmed: 30595452
Nat Commun. 2019 Oct 17;10(1):4706
pubmed: 31624246
Nat Commun. 2019 Nov 28;10(1):5415
pubmed: 31780669
Cell. 2016 Apr 21;165(3):535-50
pubmed: 27104977
Methods Mol Biol. 2017;1514:187-202
pubmed: 27787802
PLoS Biol. 2011 Apr;9(4):e1000607
pubmed: 21532732
Curr Protoc Immunol. 2017 Apr 3;117:5.4.1-5.4.38
pubmed: 28369683
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Cell Rep. 2020 Apr 7;31(1):107499
pubmed: 32268080
Cell. 2008 Oct 17;135(2):216-26
pubmed: 18957198
Nature. 2019 Dec;576(7786):293-300
pubmed: 31802004
Genome Med. 2020 Jun 24;12(1):55
pubmed: 32580776
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389859
Nat Rev Immunol. 2018 Jan;18(1):35-45
pubmed: 28787399
Nat Commun. 2018 Nov 6;9(1):4638
pubmed: 30401874
Cytometry A. 2014 Dec;85(12):1037-48
pubmed: 25346474
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601